A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter

Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisione...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-03, Vol.10 (3), p.e0122253
Hauptverfasser: Chambers, Christopher B, Halford, William P, Geltz, Joshua, Villamizar, Olga, Gross, Jeffrey, Embalabala, Alison, Gershburg, Edward, Wilber, Andrew
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page e0122253
container_title PloS one
container_volume 10
creator Chambers, Christopher B
Halford, William P
Geltz, Joshua
Villamizar, Olga
Gross, Jeffrey
Embalabala, Alison
Gershburg, Edward
Wilber, Andrew
description Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.
doi_str_mv 10.1371/journal.pone.0122253
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1667659572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A419036193</galeid><doaj_id>oai_doaj_org_article_74538f029ea44fd2b4686758960c029e</doaj_id><sourcerecordid>A419036193</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-9bdd0069bfc5c9f606905b23d811e66f6b30d19e278f62e5eee7b6b3a0011d703</originalsourceid><addsrcrecordid>eNqNk12L1DAUhoso7rr6D0QDguDFjPlo0_ZmYVj8GFhY8Os2pOlJJ0va1CRdZn6G_9iM011mQEFykfD2PU8PL-dk2UuCl4SV5P2tm_wg7XJ0AywxoZQW7FF2TmpGF5xi9vjofZY9C-EW44JVnD_NzmhRUYYJO89-rVDYhQg90s4j5UFGM3QoRNlYQAqsRdYMEFDcyIhgO3oIAUnUwQDIaWSGCEmKSHvXJ70xrfGgonGpNySHFnnoJisPvA34MbGC6UcLW3Rn_JTIuxEQQWMCuAR7nj3R0gZ4Md8X2fePH75dfV5c33xaX62uF4rXNC7qpm0x5nWjVaFqzdMTFw1lbUUIcK55w3BLaqBlpTmFAgDKJokSY0LaErOL7PWBO1oXxJxmEITzkhd1UdLkWB8crZO3YvSml34nnDTij-B8J6SPRlkQZZ6i1ZjWIPNct7TJecXLoqo5Vns1sS7nv01ND62CIXppT6CnXwazEZ27Ezkrq7riCfBmBnj3c0qJ_6Pl2dXJ1JUZtEsw1ZugxConNWY8zURyLf_iSqeF3qg0T9ok_aTg3UlB8kTYxk5OIYj11y__7735cep9e-TdgLRxE5yd9uMTTo35wai8C8GDfkiOYLFfh_s0xH4dxLwOqezVceoPRffzz34D5vUGqQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1667659572</pqid></control><display><type>article</type><title>A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Chambers, Christopher B ; Halford, William P ; Geltz, Joshua ; Villamizar, Olga ; Gross, Jeffrey ; Embalabala, Alison ; Gershburg, Edward ; Wilber, Andrew</creator><contributor>Kues, Wilfried A.</contributor><creatorcontrib>Chambers, Christopher B ; Halford, William P ; Geltz, Joshua ; Villamizar, Olga ; Gross, Jeffrey ; Embalabala, Alison ; Gershburg, Edward ; Wilber, Andrew ; Kues, Wilfried A.</creatorcontrib><description>Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0122253</identifier><identifier>PMID: 25823013</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Antibiotics ; Biology ; Biotechnology ; Cell Line ; Cell Line, Tumor ; Cell lines ; Chromosomes ; Cloning ; DNA Transposable Elements ; Doxycycline ; Doxycycline - pharmacology ; Drug resistance ; Gene expression ; Gene Expression - drug effects ; Gene Expression - genetics ; Gene Expression Regulation, Viral - drug effects ; Gene Expression Regulation, Viral - genetics ; Genes ; Genetic engineering ; Genomes ; HEK293 Cells ; HeLa Cells ; Herpes simplex ; Herpes simplex virus ; Herpes viruses ; Herpesvirus 1, Human - genetics ; Humans ; Immunology ; Integration ; Medicine ; Plasmids ; Promoter Regions, Genetic - drug effects ; Promoter Regions, Genetic - genetics ; Proteins ; Tetracycline - pharmacology ; Trans-Activators - pharmacology ; Transcription ; Transcription, Genetic - drug effects ; Transcription, Genetic - genetics ; Viruses ; VP16 protein</subject><ispartof>PloS one, 2015-03, Vol.10 (3), p.e0122253</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Chambers et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Chambers et al 2015 Chambers et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-9bdd0069bfc5c9f606905b23d811e66f6b30d19e278f62e5eee7b6b3a0011d703</citedby><cites>FETCH-LOGICAL-c692t-9bdd0069bfc5c9f606905b23d811e66f6b30d19e278f62e5eee7b6b3a0011d703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378986/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378986/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2100,2926,23864,27922,27923,53789,53791,79370,79371</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25823013$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kues, Wilfried A.</contributor><creatorcontrib>Chambers, Christopher B</creatorcontrib><creatorcontrib>Halford, William P</creatorcontrib><creatorcontrib>Geltz, Joshua</creatorcontrib><creatorcontrib>Villamizar, Olga</creatorcontrib><creatorcontrib>Gross, Jeffrey</creatorcontrib><creatorcontrib>Embalabala, Alison</creatorcontrib><creatorcontrib>Gershburg, Edward</creatorcontrib><creatorcontrib>Wilber, Andrew</creatorcontrib><title>A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.</description><subject>Antibiotics</subject><subject>Biology</subject><subject>Biotechnology</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Cell lines</subject><subject>Chromosomes</subject><subject>Cloning</subject><subject>DNA Transposable Elements</subject><subject>Doxycycline</subject><subject>Doxycycline - pharmacology</subject><subject>Drug resistance</subject><subject>Gene expression</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - genetics</subject><subject>Gene Expression Regulation, Viral - drug effects</subject><subject>Gene Expression Regulation, Viral - genetics</subject><subject>Genes</subject><subject>Genetic engineering</subject><subject>Genomes</subject><subject>HEK293 Cells</subject><subject>HeLa Cells</subject><subject>Herpes simplex</subject><subject>Herpes simplex virus</subject><subject>Herpes viruses</subject><subject>Herpesvirus 1, Human - genetics</subject><subject>Humans</subject><subject>Immunology</subject><subject>Integration</subject><subject>Medicine</subject><subject>Plasmids</subject><subject>Promoter Regions, Genetic - drug effects</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Proteins</subject><subject>Tetracycline - pharmacology</subject><subject>Trans-Activators - pharmacology</subject><subject>Transcription</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transcription, Genetic - genetics</subject><subject>Viruses</subject><subject>VP16 protein</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12L1DAUhoso7rr6D0QDguDFjPlo0_ZmYVj8GFhY8Os2pOlJJ0va1CRdZn6G_9iM011mQEFykfD2PU8PL-dk2UuCl4SV5P2tm_wg7XJ0AywxoZQW7FF2TmpGF5xi9vjofZY9C-EW44JVnD_NzmhRUYYJO89-rVDYhQg90s4j5UFGM3QoRNlYQAqsRdYMEFDcyIhgO3oIAUnUwQDIaWSGCEmKSHvXJ70xrfGgonGpNySHFnnoJisPvA34MbGC6UcLW3Rn_JTIuxEQQWMCuAR7nj3R0gZ4Md8X2fePH75dfV5c33xaX62uF4rXNC7qpm0x5nWjVaFqzdMTFw1lbUUIcK55w3BLaqBlpTmFAgDKJokSY0LaErOL7PWBO1oXxJxmEITzkhd1UdLkWB8crZO3YvSml34nnDTij-B8J6SPRlkQZZ6i1ZjWIPNct7TJecXLoqo5Vns1sS7nv01ND62CIXppT6CnXwazEZ27Ezkrq7riCfBmBnj3c0qJ_6Pl2dXJ1JUZtEsw1ZugxConNWY8zURyLf_iSqeF3qg0T9ok_aTg3UlB8kTYxk5OIYj11y__7735cep9e-TdgLRxE5yd9uMTTo35wai8C8GDfkiOYLFfh_s0xH4dxLwOqezVceoPRffzz34D5vUGqQ</recordid><startdate>20150330</startdate><enddate>20150330</enddate><creator>Chambers, Christopher B</creator><creator>Halford, William P</creator><creator>Geltz, Joshua</creator><creator>Villamizar, Olga</creator><creator>Gross, Jeffrey</creator><creator>Embalabala, Alison</creator><creator>Gershburg, Edward</creator><creator>Wilber, Andrew</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150330</creationdate><title>A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter</title><author>Chambers, Christopher B ; Halford, William P ; Geltz, Joshua ; Villamizar, Olga ; Gross, Jeffrey ; Embalabala, Alison ; Gershburg, Edward ; Wilber, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-9bdd0069bfc5c9f606905b23d811e66f6b30d19e278f62e5eee7b6b3a0011d703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antibiotics</topic><topic>Biology</topic><topic>Biotechnology</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Cell lines</topic><topic>Chromosomes</topic><topic>Cloning</topic><topic>DNA Transposable Elements</topic><topic>Doxycycline</topic><topic>Doxycycline - pharmacology</topic><topic>Drug resistance</topic><topic>Gene expression</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - genetics</topic><topic>Gene Expression Regulation, Viral - drug effects</topic><topic>Gene Expression Regulation, Viral - genetics</topic><topic>Genes</topic><topic>Genetic engineering</topic><topic>Genomes</topic><topic>HEK293 Cells</topic><topic>HeLa Cells</topic><topic>Herpes simplex</topic><topic>Herpes simplex virus</topic><topic>Herpes viruses</topic><topic>Herpesvirus 1, Human - genetics</topic><topic>Humans</topic><topic>Immunology</topic><topic>Integration</topic><topic>Medicine</topic><topic>Plasmids</topic><topic>Promoter Regions, Genetic - drug effects</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Proteins</topic><topic>Tetracycline - pharmacology</topic><topic>Trans-Activators - pharmacology</topic><topic>Transcription</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transcription, Genetic - genetics</topic><topic>Viruses</topic><topic>VP16 protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chambers, Christopher B</creatorcontrib><creatorcontrib>Halford, William P</creatorcontrib><creatorcontrib>Geltz, Joshua</creatorcontrib><creatorcontrib>Villamizar, Olga</creatorcontrib><creatorcontrib>Gross, Jeffrey</creatorcontrib><creatorcontrib>Embalabala, Alison</creatorcontrib><creatorcontrib>Gershburg, Edward</creatorcontrib><creatorcontrib>Wilber, Andrew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chambers, Christopher B</au><au>Halford, William P</au><au>Geltz, Joshua</au><au>Villamizar, Olga</au><au>Gross, Jeffrey</au><au>Embalabala, Alison</au><au>Gershburg, Edward</au><au>Wilber, Andrew</au><au>Kues, Wilfried A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-03-30</date><risdate>2015</risdate><volume>10</volume><issue>3</issue><spage>e0122253</spage><pages>e0122253-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25823013</pmid><doi>10.1371/journal.pone.0122253</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-03, Vol.10 (3), p.e0122253
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1667659572
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Antibiotics
Biology
Biotechnology
Cell Line
Cell Line, Tumor
Cell lines
Chromosomes
Cloning
DNA Transposable Elements
Doxycycline
Doxycycline - pharmacology
Drug resistance
Gene expression
Gene Expression - drug effects
Gene Expression - genetics
Gene Expression Regulation, Viral - drug effects
Gene Expression Regulation, Viral - genetics
Genes
Genetic engineering
Genomes
HEK293 Cells
HeLa Cells
Herpes simplex
Herpes simplex virus
Herpes viruses
Herpesvirus 1, Human - genetics
Humans
Immunology
Integration
Medicine
Plasmids
Promoter Regions, Genetic - drug effects
Promoter Regions, Genetic - genetics
Proteins
Tetracycline - pharmacology
Trans-Activators - pharmacology
Transcription
Transcription, Genetic - drug effects
Transcription, Genetic - genetics
Viruses
VP16 protein
title A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A15%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20system%20for%20creating%20stable%20cell%20lines%20that%20express%20a%20gene%20of%20interest%20from%20a%20bidirectional%20and%20regulatable%20herpes%20simplex%20virus%20type%201%20promoter&rft.jtitle=PloS%20one&rft.au=Chambers,%20Christopher%20B&rft.date=2015-03-30&rft.volume=10&rft.issue=3&rft.spage=e0122253&rft.pages=e0122253-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0122253&rft_dat=%3Cgale_plos_%3EA419036193%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1667659572&rft_id=info:pmid/25823013&rft_galeid=A419036193&rft_doaj_id=oai_doaj_org_article_74538f029ea44fd2b4686758960c029e&rfr_iscdi=true